Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Feb 26, 2021 37.00 -3.90   
 24Storage 24STOR Feb 26, 2021 42.50 +1.43   
 2cureX 2CUREX Feb 26, 2021 27.30 -1.09   
 AAC Clyde Space AAC Feb 26, 2021 3.21 -4.89   
 AAK AAK Feb 26, 2021 180.95 -0.08   
 ABB ABB Feb 26, 2021 241.90 -0.90   
 Abelco Investment Group ABIG Feb 26, 2021 0.12 -2.44   
 ABG Sundal Collier Holding ABGO Feb 26, 2021 6.30 0.00   
 Abliva ABLI Feb 26, 2021 0.73 +1.39   
 Absolent Group ABSO Feb 26, 2021 401.00 +0.75   
 Absolicon ABSL Feb 26, 2021 150.00 -3.85   
 AcadeMedia ACAD Feb 26, 2021 84.50 -0.12   
 Acarix ACARIX Feb 26, 2021 1.08 -3.14   
 Acconeer ACCON Feb 26, 2021 26.10 -1.88   
 Acosense ACOS Feb 26, 2021 1.50 +0.33   
 AcouSort ACOU Feb 26, 2021 21.50 -1.38   
 Acrinova ACRI Feb 26, 2021 22.20 0.00   
 ACROUD ACROUD Feb 26, 2021 2.66 -0.37   
 Actic Group ATIC Feb 26, 2021 17.20 +5.20   
 Active Biotech ACTI Feb 26, 2021 1.57 +0.38   
 AcuCort ACUC Feb 26, 2021 5.00 +5.49   
 Adapteo ADAPT Feb 26, 2021 94.90 +3.38   
 AdderaCare ADDERA Feb 26, 2021 5.90 -2.48   
 AddLife B ALIFB Feb 26, 2021 177.00 +2.91   
 Addnode Group B ANODB Feb 26, 2021 243.50 +1.67   
 Addtech B ADDTB Feb 26, 2021 123.00 0.00   
 ADDvise Group A ADDVA Feb 26, 2021 2.48 0.00   
 ADDvise Group B ADDVB Feb 26, 2021 1.60 -3.32   
 Adevinta ADEO Feb 26, 2021 121.50 -4.63   
 Advenica ADVE Feb 26, 2021 5.06 +1.20   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK